Medacta s P-Family Hip System offering is now more complete with the introduction of the new SMS Collared Stem finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
EQS-News: Medacta Group SA: Medacta Announces First U.S. Surgery with the New M.U.S.T. LT System in Minimally Invasive Spine Surgery
Medacta Announces First U.S. Surgery with the New M.U.S.T. LT System in Minimally Invasive Spine Surgery
28.04.2021 / 19:00
(R) LT System in Minimally Invasive Spine Surgery
CASTEL SAN PIETRO,
28 April 2021 - Medacta announced today the first surgery utilizing its M.U.S.T.
(R) LT, following clearance by the U.S. Food and Drug Administration (FDA). M.U.S.T. LT (Long Tab Screw System) is the new minimally invasive solution for posterior spine fixation in the percutaneous approach. Mainly focused on degenerative spine cases, M.U.S.T. LT expands the benefits of a percutaneous approach in spine deformity, tumors, and trauma applications. The first surgery employing M.U.S.T. LT has been recently performed in the U.S. by Stephen Tolhurst, M.D., at Texas Back Institute, in Plano, Texas.
(R) LT System in Minimally Invasive Spine Surgery
CASTEL SAN PIETRO,
28 April 2021 - Medacta announced today the first surgery utilizing its M.U.S.T.
(R) LT, following clearance by the U.S. Food and Drug Administration (FDA). M.U.S.T. LT (Long Tab Screw System) is the new minimally invasive solution for posterior spine fixation in the percutaneous approach. Mainly focused on degenerative spine cases, M.U.S.T. LT expands the benefits of a percutaneous approach in spine deformity, tumors, and trauma applications. The first surgery employing M.U.S.T. LT has been recently performed in the U.S. by Stephen Tolhurst, M.D., at Texas Back Institute, in Plano, Texas.
EQS-News: Medacta Group SA: Medacta Adds the MyHip Planner and the MyHip Verifier Tools to its Personalized Medicine Solutions for Hip Replacement
(R) Verifier Tools to its Personalized Medicine Solutions for Hip Replacement
CASTEL SAN PIETRO,
15 February 2021 - Medacta is proud to announce that it has received clearance from the U.S. Food and Drug Administration (FDA) for its MyHip
(R) Planner and MyHip
(R) Verifier, after recently receiving CE marking and approval from Australia s Therapeutic Goods Administration (TGA) and from the Japanese Ministry of Health, Labour and Welfare (MHLW). These two promising innovative technologies will be introduced into all markets in which Medacta operates in the upcoming months.